Dexmedetomidine Versus Triamcinolone Treatment of Carpal Tunnel Syndrome
CompletedNot applicableNCT04961281
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Carpal tunnel syndrome (CTS) is a common mononeuropathy due to entrapment of the median nerve in the carpal tunnel. a lot of modaleties are available for treatment of mild to moderate CTS.
Study details
- Official title
- Dexmedetomidine Versus Triamcinolone Local Injection for Pain Alleviation in Patients With Carpal Tunnel Syndrome; A Randomized Clinical Trial
- Conditions
- Interventions
- Sponsor
- Assiut University
- Start date
- 2021-07-22
- Primary completion
- 2022-07-31
- Sex
- All
- Age range
- from 20 Years to 60 Years
- Results posted
- No results posted in this snapshot
- Countries
- Egypt
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * adult patients * complaining of carpal tunnel syndrome of 3 month duration or more * diagnosed axonal neuropathy using electrodiagnosis , nerve conduction study Exclusion Criteria: * patient refusal * infection at the site of intervention * allergy to utilized drugs * diabetic * previous surgery in the site of injection * previous injection in the targeted site within the last year
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04961281